|
humans |
50 |
|
animals |
49 |
|
coronavirus |
38 |
|
influenza |
38 |
|
molecular sequence data |
37 |
|
sars-cov-2 |
37 |
|
phylogeny |
31 |
|
hong kong - epidemiology |
27 |
|
covid-19 |
24 |
|
genome, viral |
22 |
|
china |
21 |
|
reverse transcriptase polymerase chain reaction |
20 |
|
hong kong |
19 |
|
influenza virus |
19 |
|
base sequence |
18 |
|
evolution, molecular |
18 |
|
swine |
18 |
|
universal vaccine |
18 |
|
china - epidemiology |
17 |
|
virus evolution |
17 |
|
adult |
16 |
|
cercopithecus aethiops |
16 |
|
disease outbreaks |
16 |
|
influenza a |
16 |
|
respiratory system - virology |
16 |
|
sars coronavirus |
16 |
|
sequence analysis, dna |
16 |
|
genotype |
15 |
|
mers-cov |
15 |
|
rna, viral - genetics |
15 |
|
sars |
15 |
|
birds - virology |
14 |
|
disease outbreaks - statistics & numerical data |
14 |
|
poultry - virology |
14 |
|
sars virus - metabolism - pathogenicity |
14 |
|
swine - virology |
14 |
|
aged |
13 |
|
conjunctiva - virology |
13 |
|
coronavirus - classification - genetics - isolation & purification |
13 |
|
female |
13 |
|
genetic variation |
13 |
|
male |
13 |
|
molecular epidemiology |
13 |
|
viral proteins - genetics |
13 |
|
amino acid sequence |
12 |
|
astroviridae infections - epidemiology - veterinary - virology |
12 |
|
bronchi - cytology |
12 |
|
evolution |
12 |
|
influenza a virus, h1n1 subtype - metabolism |
12 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
12 |
|
influenza, human - epidemiology - virology |
12 |
|
influenza, human - virology |
12 |
|
pandemics |
12 |
|
proteasome endopeptidase complex - metabolism |
12 |
|
species specificity |
12 |
|
t cells |
12 |
|
time factors |
12 |
|
transmission |
12 |
|
virus replication |
12 |
|
zoonosis |
12 |
|
adolescent |
11 |
|
africa |
11 |
|
antibodies, viral - blood |
11 |
|
avian influenza |
11 |
|
cell adhesion molecules - genetics - metabolism |
11 |
|
chiroptera - virology |
11 |
|
cho cells - virology |
11 |
|
cohort studies |
11 |
|
coronaviruses |
11 |
|
cricetinae |
11 |
|
cricetulus |
11 |
|
feces - virology |
11 |
|
ferrets - virology |
11 |
|
genetic predisposition to disease |
11 |
|
h7n9 |
11 |
|
homozygote |
11 |
|
intestine, small - physiology |
11 |
|
lectins, c-type - genetics - metabolism |
11 |
|
lung - physiology - virology |
11 |
|
polymerase chain reaction - methods |
11 |
|
receptors, cell surface - genetics - metabolism |
11 |
|
sars virus - genetics |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
species index: animalia |
11 |
|
surveillance |
11 |
|
tandem repeat sequences |
11 |
|
vero cells - virology |
11 |
|
avian |
10 |
|
birds |
10 |
|
chemicals and cas registry numbers |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
genes, viral |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics |
10 |
|
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - metabolism |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - metabolism - transmission |
10 |
|
ip-10 |
10 |
|
mers |
10 |
|
neuraminidase - genetics |
10 |
|
organ culture techniques |
10 |
|
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
10 |
|
polymerase chain reaction |
10 |
|
population surveillance |
10 |
|
prevalence |
10 |
|
reassortant viruses - isolation & purification |
10 |
|
receptors, cell surface - metabolism |
10 |
|
respiratory mucosa - virology |
10 |
|
sars virus - genetics - isolation & purification |
10 |
|
viral tropism |
10 |
|
virulence |
10 |
|
virus attachment |
10 |
|
cells, cultured |
9 |
|
chiroptera - classification - virology |
9 |
|
coronavirus - classification - genetics |
9 |
|
h1n1 |
9 |
|
human |
9 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification |
9 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
|
influenza a virus, h3n2 subtype - classification - genetics - isolation & purification |
9 |
|
kinetics |
9 |
|
mamastrovirus - classification - genetics - isolation & purification |
9 |
|
middle aged |
9 |
|
molecular sequence numbers |
9 |
|
pneumonia, viral - virology |
9 |
|
reverse transcriptase polymerase chain reaction - methods |
9 |
|
rna interference |
9 |
|
rna, viral - analysis - genetics |
9 |
|
rt-qpcr |
9 |
|
sars virus - isolation & purification |
9 |
|
serology |
9 |
|
swine - blood - virology |
9 |
|
swine diseases - blood - epidemiology - transmission - virology |
9 |
|
wastewater surveillance |
9 |
|
adaptation, biological |
8 |
|
animals, wild - virology |
8 |
|
antibody-dependent cellular cytotoxicity |
8 |
|
baseline immunity |
8 |
|
betacoronavirus |
8 |
|
bronchi - immunology - pathology |
8 |
|
canada - epidemiology |
8 |
|
characterization |
8 |
|
chemokines |
8 |
|
cluster analysis |
8 |
|
coronavirus infection |
8 |
|
coronavirus infections |
8 |
|
coronavirus infections - veterinary - virology |
8 |
|
cytokines - immunology |
8 |
|
databases, nucleic acid - statistics & numerical data |
8 |
|
disease progression |
8 |
|
epidemiology |
8 |
|
ha stem antibodies |
8 |
|
heterosubtypic immunity |
8 |
|
immunity |
8 |
|
influenza a virus - genetics |
8 |
|
influenza a virus, h5n1 subtype - immunology |
8 |
|
influenza virus infection |
8 |
|
middle east respiratory syndrome coronavirus |
8 |
|
nucleic acid amplification techniques - methods |
8 |
|
pandemic h1n1 |
8 |
|
pathogenesis |
8 |
|
pathogenicity |
8 |
|
phenotype |
8 |
|
positive selection |
8 |
|
pulmonary alveoli - immunology |
8 |
|
reassortant viruses - classification - genetics - isolation & purification |
8 |
|
respiratory mucosa - immunology - pathology |
8 |
|
sars virus - genetics - immunology |
8 |
|
sensitivity and specificity |
8 |
|
sequence homology |
8 |
|
severe acute respiratory syndrome - epidemiology - transmission - virology |
8 |
|
singapore - epidemiology |
8 |
|
universal immune correlate |
8 |
|
vietnam - epidemiology |
8 |
|
viral proteins - chemistry - genetics |
8 |
|
5′-race assay |
7 |
|
amplicon |
7 |
|
antibodies |
7 |
|
antibody |
7 |
|
antigens, viral - analysis |
7 |
|
astroviridae - classification - genetics - isolation and purification |
7 |
|
bayes theorem |
7 |
|
blood |
7 |
|
bronchial tissue |
7 |
|
cell-mediated immunity |
7 |
|
consensus sequence |
7 |
|
coronavirus - classification - enzymology - genetics - isolation & purification |
7 |
|
disease outbreaks - history |
7 |
|
disease reservoirs |
7 |
|
dna primers |
7 |
|
early warnings |
7 |
|
etiology |
7 |
|
felidae - virology |
7 |
|
fractional factorial design |
7 |
|
genomic sequence |
7 |
|
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
|
history, 20th century |
7 |
|
history, 21st century |
7 |
|
influenza a virus - classification - genetics |
7 |
|
influenza a virus - classification - genetics - isolation & purification |
7 |
|
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
|
influenza in birds - epidemiology - virology |
7 |
|
influenza in birds - transmission - virology |
7 |
|
influenza, human - epidemiology - history |
7 |
|
influenza, human - epidemiology - transmission - virology |
7 |
|
influenza, human - transmission - virology |
7 |
|
models, genetic |
7 |
|
molecular clock |
7 |
|
mustelidae - virology |
7 |
|
nasal tissue |
7 |
|
nasopharynx - virology |
7 |
|
nasopharynx/virology |
7 |
|
neuraminidase - metabolism |
7 |
|
neutralization tests |
7 |
|
nucleocapsid proteins - genetics |
7 |
|
omicron ba.2 |
7 |
|
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
|
public health |
7 |
|
reassortant |
7 |
|
rna helicases - genetics |
7 |
|
rna replicase - genetics |
7 |
|
rna, viral - analysis |
7 |
|
rodent diseases - virology |
7 |
|
rt-pcr |
7 |
|
sars cov |
7 |
|
sars virus - isolation and purification |
7 |
|
saudi arabia |
7 |
|
serotyping |
7 |
|
severe acute respiratory syndrome |
7 |
|
severe acute respiratory syndrome - blood - physiopathology - urine - virology |
7 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - virology |
7 |
|
severe acute respiratory syndrome - epidemiology - history - virology |
7 |
|
severe acute respiratory syndrome - virology |
7 |
|
sewage surveillance |
7 |
|
sewage system characteristics |
7 |
|
subgenomic transcripts |
7 |
|
vaccination |
7 |
|
viral genes |
7 |
|
viral load |
7 |
|
virology - methods |
7 |
|
2019 novel coronavirus disease |
6 |
|
abattoirs |
6 |
|
administration, oral |
6 |
|
aerosols |
6 |
|
air travel-related outbreak |
6 |
|
alveolar epithelial cells |
6 |
|
amoxicillin-potassium clavulanate combination - administration & dosage |
6 |
|
antibodies, monoclonal - diagnostic use |
6 |
|
biodiversity |
6 |
|
biodiversity conservation |
6 |
|
biopsy |
6 |
|
blotting, western |
6 |
|
bronchi - pathology |
6 |
|
camel |
6 |
|
carnivora - virology |
6 |
|
cell nucleus - ultrastructure |
6 |
|
child, preschool |
6 |
|
clade 2.3.4.4.b |
6 |
|
conservation of natural resources |
6 |
|
coronavirus - classification - genetics - immunology - isolation & purification |
6 |
|
coronavirus - classification - isolation & purification - ultrastructure |
6 |
|
coronavirus 229e, human - immunology |
6 |
|
coronavirus disease |
6 |
|
coronavirus infections - diagnosis - transmission - virology |
6 |
|
coronavirus oc43, human - immunology |
6 |
|
cross infection - complications |
6 |
|
cross-reactive antibody response |
6 |
|
cytokine |
6 |
|
cytokines - biosynthesis - genetics |
6 |
|
cytokines - genetics - metabolism |
6 |
|
cytopathogenic effect, viral |
6 |
|
disease transmission control |
6 |
|
dna helicases - classification - genetics - metabolism |
6 |
|
dna, viral - classification - genetics |
6 |
|
dna, viral - genetics |
6 |
|
dna, viral - genetics - metabolism |
6 |
|
ducks - virology |
6 |
|
early diagnosis |
6 |
|
family characteristics |
6 |
|
far east - epidemiology |
6 |
|
fatal outcome |
6 |
|
follow-up studies |
6 |
|
gene expression regulation |
6 |
|
genes, viral - genetics |
6 |
|
genomic diversity |
6 |
|
genomic epidemiology |
6 |
|
giant cells - ultrastructure |
6 |
|
h5n1 |
6 |
|
hiv protease inhibitors - therapeutic use |
6 |
|
hospitalization |
6 |
|
hpai |
6 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification - pathogenicity |
6 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
6 |
|
influenza a virus, h1n2 subtype - classification - genetics - isolation & purification |
6 |
|
influenza a virus, h3n2 subtype - genetics - pathogenicity |
6 |
|
influenza a virus, h5n1 subtype - classification - genetics |
6 |
|
influenza a(h1n1)pdm09 |
6 |
|
influenza a(h5n1) |
6 |
|
influenza in birds - diagnosis - genetics - virology |
6 |
|
influenza polymerase |
6 |
|
influenza, human - diagnosis - genetics - virology |
6 |
|
influenza, human - immunology - virology |
6 |
|
influenza, human - transmission |
6 |
|
influenzavirus a - genetics - immunology - pathogenicity |
6 |
|
infusions, intravenous |
6 |
|
length of stay |
6 |
|
lung - pathology - virology |
6 |
|
lung - radiography |
6 |
|
macrophages - immunology |
6 |
|
macrophages - immunology - virology |
6 |
|
membrane glycoproteins - chemistry - genetics |
6 |
|
metaplasia |
6 |
|
microscopy, electron |
6 |
|
molecular diagnostic techniques - methods |
6 |
|
mutation - genetics |
6 |
|
nasal cavity - virology |
6 |
|
neuraminidase inhibition antibody |
6 |
|
neutralization |
6 |
|
nose - virology |
6 |
|
nsp6 |
6 |
|
nucleocapsid proteins - analysis |
6 |
|
nucleoside-triphosphatase - classification - genetics - metabolism |
6 |
|
ofloxacin |
6 |
|
open reading frames - genetics |
6 |
|
opportunistic infections - diagnosis - transmission - virology |
6 |
|
organ size |
6 |
|
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
|
orthomyxoviridae infections - transmission |
6 |
|
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
|
owston's civet |
6 |
|
pandemic risk assessment |
6 |
|
pharynx - virology |
6 |
|
polymorphism, genetic |
6 |
|
pregnancy |
6 |
|
pregnancy complications, infectious - diagnosis - therapy |
6 |
|
prospective studies |
6 |
|
pulse therapy, drug |
6 |
|
pyrimidinones - therapeutic use |
6 |
|
quantitative rt-pcr |
6 |
|
real time rt-pcr |
6 |
|
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
|
regional index: china |
6 |
|
residence characteristics |
6 |
|
respiratory infections |
6 |
|
respiratory tract infections |
6 |
|
reverse transcriptase polymerase chain reaction - methods - standards |
6 |
|
risk assessment |
6 |
|
risk factors |
6 |
|
ritonavir - therapeutic use |
6 |
|
rna helicases - classification - genetics - metabolism |
6 |
|
rna, messenger - analysis |
6 |
|
rna, viral |
6 |
|
rna, viral - analysis - isolation & purification |
6 |
|
rna, viral - genetics - isolation & purification |
6 |
|
sars coronavirus 2 |
6 |
|
sars virus - classification - genetics - immunology - isolation & purification |
6 |
|
sars virus - enzymology - genetics |
6 |
|
sars virus - genetics - immunology - isolation & purification |
6 |
|
sars virus - immunology |
6 |
|
sars virus - pathogenicity |
6 |
|
sars virus - physiology |
6 |
|
seasons |
6 |
|
sequence deletion |
6 |
|
sequence homology, amino acid |
6 |
|
sequence homology, nucleic acid |
6 |
|
sequence variation |
6 |
|
seroepidemiology |
6 |
|
severe acute respiratory syndrome - blood - immunology |
6 |
|
severe acute respiratory syndrome - complications - pathology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - drug therapy - epidemiology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - immunology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - virology |
6 |
|
severe acute respiratory syndrome - drug therapy - virology |
6 |
|
severe acute respiratory syndrome - epidemiology - microbiology |
6 |
|
severe acute respiratory syndrome - immunology - virology |
6 |
|
severe acute respiratory syndrome - mortality - physiopathology - virology |
6 |
|
severity of illness index |
6 |
|
specimen handling |
6 |
|
substrate specificity |
6 |
|
survival rate |
6 |
|
swine diseases - epidemiology - transmission - virology |
6 |
|
tumor necrosis factor-alpha - biosynthesis - genetics |
6 |
|
variant |
6 |
|
vero cells |
6 |
|
viral envelope proteins - chemistry - genetics |
6 |
|
viral load - statistics & numerical data |
6 |
|
viral proteins - genetics - metabolism |
6 |
|
virus cultivation |
6 |
|
viruses |
6 |
|
viverrid |
6 |
|
viverridae - anatomy & histology - physiology - virology |
6 |
|
wastewater genome sequencing |
6 |
|
wastewater-based epidemiology |
6 |
|
whole genome sequencing |
6 |
|
wild species infections |
6 |
|
actins - genetics |
5 |
|
adaptation |
5 |
|
adcc |
5 |
|
adjuvant |
5 |
|
amino acid substitution |
5 |
|
b cell |
5 |
|
betacoronaviruses |
5 |
|
calibration |
5 |
|
cell line |
5 |
|
chicken meat |
5 |
|
communicable diseases, emerging |
5 |
|
comorbidity |
5 |
|
consensus primers |
5 |
|
coronavirus - classification - isolation and purification |
5 |
|
coronavirus - genetics - isolation & purification |
5 |
|
cytokines - metabolism |
5 |
|
deubiquitylases |
5 |
|
diagnostics |
5 |
|
diarrhea |
5 |
|
dna, complementary - analysis |
5 |
|
dna, protozoan - blood - genetics |
5 |
|
dna, ribosomal - analysis |
5 |
|
dna, viral - analysis - genetics |
5 |
|
dna, viral - chemistry - genetics |
5 |
|
dromedary camels |
5 |
|
feces analysis |
5 |
|
fomite |
5 |
|
gyrovirus |
5 |
|
ha stem |
5 |
|
haplorhini |
5 |
|
hemagglutinin glycoproteins, influenza virus - classification - genetics |
5 |
|
hot temperature |
5 |
|
immunohistochemistry |
5 |
|
indirubin |
5 |
|
infection |
5 |
|
influenza a virus |
5 |
|
influenza a virus - classification - enzymology - genetics |
5 |
|
influenza a virus - enzymology - genetics |
5 |
|
influenza a virus - genetics - isolation & purification |
5 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification |
5 |
|
influenza a virus, h2n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h3n2 subtype - classification - genetics - isolation and purification |
5 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
5 |
|
influenza in birds - enzymology |
5 |
|
influenza in birds - epidemiology - genetics |
5 |
|
influenza, human - diagnosis - virology |
5 |
|
innate immune response |
5 |
|
interferon type i - pharmacology |
5 |
|
interferon-gamma - pharmacology |
5 |
|
macrophages |
5 |
|
malaria, falciparum - blood - diagnosis |
5 |
|
mammals - virology |
5 |
|
membrane glycoproteins - genetics |
5 |
|
methods |
5 |
|
molecular diagnostic techniques - economics - methods |
5 |
|
mpox virus |
5 |
|
mutation |
5 |
|
mutations |
5 |
|
norovirus |
5 |
|
nucleoprotein |
5 |
|
omicron |
5 |
|
omicron variants |
5 |
|
open reading frames |
5 |
|
orthomyxoviridae infections - diagnosis - virology |
5 |
|
orthomyxoviridae infections - epidemiology - veterinary - virology |
5 |
|
plasmodium falciparum - genetics - isolation & purification |
5 |
|
pneumocytes |
5 |
|
polymerase |
5 |
|
polymerase chain reaction - economics - methods - standards |
5 |
|
polymerase genes |
5 |
|
rapid diagnosis |
5 |
|
reagent kits, diagnostic |
5 |
|
real-time pcr |
5 |
|
reassortant viruses - classification - genetics - isolation and purification |
5 |
|
reference standards |
5 |
|
reverse transcriptase polymerase chain reaction - economics - methods |
5 |
|
rig-i signaling |
5 |
|
rna replicase - chemistry - genetics |
5 |
|
rna virus |
5 |
|
rna, ribosomal, 18s - genetics |
5 |
|
rna, viral - analysis - genetics - isolation & purification |
5 |
|
rna, viral - biosynthesis |
5 |
|
rotavirus |
5 |
|
sars virus - genetics - growth & development - isolation & purification |
5 |
|
selection |
5 |
|
sequencing |
5 |
|
serial passage |
5 |
|
severe acute respiratory syndrome - blood - mortality - virology |
5 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
|
specimen handling - methods |
5 |
|
swine diseases - epidemiology - virology |
5 |
|
syrian hamsters |
5 |
|
ubiquitylation |
5 |
|
viral envelope proteins - genetics |
5 |
|
viral matrix proteins - genetics |
5 |
|
virus dna |
5 |
|
virus replication - drug effects |
5 |
|
2019 ncov whu01 |
4 |
|
adjuvants, immunologic - administration and dosage |
4 |
|
algorithm |
4 |
|
animal experiment |
4 |
|
animal model |
4 |
|
animal tissue |
4 |
|
antibody dependent enhancement |
4 |
|
antigen binding |
4 |
|
antigen detection |
4 |
|
antigens, viral - analysis - immunology |
4 |
|
betacov/nepal/61/2020 |
4 |
|
bioinformatics |
4 |
|
chemistry |
4 |
|
clinical trials |
4 |
|
coating |
4 |
|
codon usage analysis |
4 |
|
cohort |
4 |
|
communicable diseases, emerging - epidemiology - virology |
4 |
|
coronavirus infections - diagnosis - mortality |
4 |
|
cross‐neutralization |
4 |
|
digital rt-pcr |
4 |
|
disease association |
4 |
|
disease surveillance |
4 |
|
dromedary |
4 |
|
dromedary camel |
4 |
|
elisa |
4 |
|
equine coronavirus |
4 |
|
ethiopia |
4 |
|
genetics |
4 |
|
hajj |
4 |
|
hemagglutinin-stalk |
4 |
|
hku23 |
4 |
|
il-15 |
4 |
|
immunity, duration |
4 |
|
immunoassay - methods |
4 |
|
immunology |
4 |
|
influenza a virus - classification - genetics - growth & development - isolation & |
4 |
|
influenza a virus - classification - genetics - pathogenicity |
4 |
|
influenza a virus, h1n1 subtype - genetics |
4 |
|
influenza a virus, h1n1 subtype - immunology - isolation and purification |
4 |
|
influenza a virus, h5n1 subtype - classification - immunology |
4 |
|
influenza a virus, h5n1 subtype - genetics - pathogenicity |
4 |
|
influenza a virus, h9n2 subtype |
4 |
|
influenza virus vaccines |
4 |
|
influenza, human - diagnosis - mortality |
4 |
|
interleukin-15 - administration and dosage - immunology |
4 |
|
introns |
4 |
|
live vector vaccines |
4 |
|
macrophages - virology |
4 |
|
molecular diagnosis |
4 |
|
molecular typing |
4 |
|
mouse-adaptation |
4 |
|
neutralizing antibody |
4 |
|
next-generation sequencing |
4 |
|
nk cells |
4 |
|
orthomyxoviridae infections - immunology - prevention and control |
4 |
|
orthomyxoviridae infections - virology |
4 |
|
pandemic |
4 |
|
pb2 |
4 |
|
pb2-627 |
4 |
|
ph-responsive peptide |
4 |
|
point mutation |
4 |
|
point-of care |
4 |
|
protection |
4 |
|
pulmonary delivery |
4 |
|
random mutagenesis |
4 |
|
real time-pcr |
4 |
|
reassortant viruses - genetics |
4 |
|
reassortant viruses - immunology - isolation and purification |
4 |
|
reproducibility of results |
4 |
|
respiratory syncytial virus infections - diagnosis - mortality |
4 |
|
rna, viral - genetics - isolation and purification |
4 |
|
severe acute respiratory syndrome - diagnosis |
4 |
|
small interfering rna |
4 |
|
spray drying |
4 |
|
t cell |
4 |
|
tumor necrosis factor-alpha - metabolism |
4 |
|
universal vaccines |
4 |
|
vaccinia |
4 |
|
vaccinia virus - genetics - immunology |
4 |
|
viral nonstructural proteins - genetics |
4 |
|
wca |
4 |
|
abattoir |
3 |
|
age factors |
3 |
|
air travel |
3 |
|
aircraft |
3 |
|
antibodies, monoclonal - administration and dosage - genetics - immunology - therapeutic use |
3 |
|
antibodies, monoclonal - chemistry - immunology - isolation and purification |
3 |
|
antigens, viral - immunology |
3 |
|
antiviral agents - pharmacology - therapeutic use |
3 |
|
astro viruses |
3 |
|
b-lymphocytes - immunology - virology |
3 |
|
bird diseases - physiopathology - transmission - virology |
3 |
|
chimera |
3 |
|
co-infection |
3 |
|
communicable diseases, emerging - mortality - transmission - virology |
3 |
|
coronavirus disease 2019 |
3 |
|
droplet microfluidics |
3 |
|
emerging pathogens |
3 |
|
eyfp, gene encoding the enhanced yellow fluorescent protein |
3 |
|
genetic variability |
3 |
|
human respiratory viruses |
3 |
|
immunization, passive |
3 |
|
immunoglobulin m - immunology |
3 |
|
immunologic memory - immunology |
3 |
|
influenza a virus - classification - isolation & purification - pathogenicity |
3 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - pathogenicity |
3 |
|
influenza a virus, h1n1 subtype - immunology |
3 |
|
influenza a virus, h5n1 subtype |
3 |
|
influenza a virus, h5n1 subtype - genetics - isolation & purification |
3 |
|
influenza b virus |
3 |
|
influenza vaccines |
3 |
|
influenza, human - drug therapy - epidemiology - prevention & control - transmission |
3 |
|
influenza, human - epidemiology - therapy |
3 |
|
lineage differentiation |
3 |
|
livestock - virology |
3 |
|
mdck, madin-darby canine kidney |
3 |
|
membrane glycoproteins - genetics - immunology - physiology |
3 |
|
middle east respiratory syndrome |
3 |
|
novel |
3 |
|
ns1, gene encoding the non-structural protein ns1 |
3 |
|
orthomyxoviridae - drug effects - immunology - pathogenicity |
3 |
|
orthomyxoviridae - genetics - isolation and purification - pathogenicity |
3 |
|
oseltamivir - therapeutic use |
3 |
|
pandemic h1n1 2009 |
3 |
|
pandemic influenza |
3 |
|
pandemics - prevention and control |
3 |
|
ptgs, post-transcriptional gene silencing |
3 |
|
quantitative collection |
3 |
|
rapid antigen detection kit |
3 |
|
real time quantitative rt-pcr |
3 |
|
reassortant virus |
3 |
|
reassortant viruses - genetics - isolation and purification - pathogenicity |
3 |
|
respiration, artificial |
3 |
|
rnai, rna interference |
3 |
|
rt-ddpcr |
3 |
|
sars virus |
3 |
|
sars virus - classification - genetics |
3 |
|
seasonal h1n1 and h3n2 |
3 |
|
single cell |
3 |
|
sirna, small-interfering rna |
3 |
|
south-east asia |
3 |
|
swine influenza |
3 |
|
victoria |
3 |
|
vietnam |
3 |
|
yamagata |
3 |
|
2009 h1n1 influenzaanti |
2 |
|
8b protein |
2 |
|
accessory proteins |
2 |
|
accidental deaths |
2 |
|
antibiotic therapy |
2 |
|
antibodies, monoclonal - chemistry - immunology |
2 |
|
antibodies, monoclonal - immunology - isolation and purification |
2 |
|
antibodies, neutralizing - chemistry - immunology |
2 |
|
antibodies, neutralizing - immunology - isolation and purification |
2 |
|
antibodies, viral - immunology - isolation and purification |
2 |
|
antibody detection |
2 |
|
antibody production |
2 |
|
antibody vaccine |
2 |
|
antigens, viral - chemistry - genetics - immunology |
2 |
|
arterial oxygen tension |
2 |
|
artificial ventilation |
2 |
|
bacterium culture |
2 |
|
bat coronaviruses |
2 |
|
betacorona |
2 |
|
biology |
2 |
|
body response |
2 |
|
broad-spectrum vaccine |
2 |
|
case report |
2 |
|
clinical article |
2 |
|
clinical diagnosis |
2 |
|
clinical outcome |
2 |
|
codon |
2 |
|
codon usage |
2 |
|
conserved sequence |
2 |
|
contamination |
2 |
|
controlled study |
2 |
|
coronavirinae |
2 |
|
coronavirus - genetics |
2 |
|
cu2o |
2 |
|
cuo cupric oxide |
2 |
|
cuprous oxide |
2 |
|
diagnosis |
2 |
|
dinucleotide usage |
2 |
|
disease severity |
2 |
|
disease x |
2 |
|
disinfection |
2 |
|
drowning |
2 |
|
ecology |
2 |
|
emerging infectious diseases |
2 |
|
envelope (e) |
2 |
|
escherichia coli |
2 |
|
filtration |
2 |
|
flongle |
2 |
|
genome organization |
2 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - immunology |
2 |
|
hemagglutinin glycoproteins, influenza virus - immunology |
2 |
|
immunodominant epitopes - chemistry - immunology |
2 |
|
influenza b virus - immunology |
2 |
|
influenza vaccines - immunology |
2 |
|
messenger |
2 |
|
mice |
2 |
|
microbiology |
2 |
|
minion |
2 |
|
missense mutation |
2 |
|
molecular detection |
2 |
|
nanopore |
2 |
|
nidovirus |
2 |
|
novel coronaviruses |
2 |
|
orthomyxoviridae infections - prevention & control |
2 |
|
passive immunization |
2 |
|
peptide-mapping |
2 |
|
picobirnavirus - classification - genetics - isolation and purification - pathogenicity |
2 |
|
proteasome pathway |
2 |
|
protein conformation |
2 |
|
rdrp |
2 |
|
reassortment |
2 |
|
replicase |
2 |
|
respiratory system |
2 |
|
respiratory tract infections - epidemiology - transmission - veterinary - virology |
2 |
|
ring vaccination |
2 |
|
rna |
2 |
|
rna processing |
2 |
|
rna virus infections - epidemiology - transmission - veterinary - virology |
2 |
|
sars virus - genetics - isolation and purification |
2 |
|
sars virus - genetics - metabolism - physiology |
2 |
|
severe acute respiratory syndrome coronavirus (sars-cov) |
2 |
|
subgenomic mrna synthesis |
2 |
|
sus scrofa - virology |
2 |
|
swimming pools |
2 |
|
ubiquitin-independent |
2 |
|
viral diagnosis |
2 |
|
viral envelope proteins - metabolism |
2 |
|
viral proteins - metabolism |
2 |
|
viricidal |
2 |
|
virus |
2 |
|
virus culture |
2 |
|
virus replication - genetics |
2 |
|
acidic polymerase protein (pa) avian influenza |
1 |
|
adenosine triphosphate - metabolism |
1 |
|
antiviral agent |
1 |
|
apoptosis |
1 |
|
apoptosis - drug effects |
1 |
|
bacterial typing techniques |
1 |
|
basic polymerase protein 1 (pb1) basic polymerase protein 2 (pb2) genomic rnas |
1 |
|
biological markers |
1 |
|
biological transport |
1 |
|
blood specimen collection - methods |
1 |
|
cd8 t cell |
1 |
|
cell death - drug effects |
1 |
|
cell differentiation |
1 |
|
cell line - virology |
1 |
|
cell nucleus - metabolism |
1 |
|
cell-free |
1 |
|
chick embryo |
1 |
|
cloning, molecular |
1 |
|
coinfection |
1 |
|
coronavirus 229e, human - classification - genetics - isolation & purification |
1 |
|
coronavirus oc43, human - classification - genetics - isolation & purification |
1 |
|
cross-reactive antibody |
1 |
|
cytotoxicity |
1 |
|
dna - blood |
1 |
|
dna - blood - genetics |
1 |
|
dna - blood - isolation & purification |
1 |
|
dna methylation |
1 |
|
dna-binding proteins - genetics - metabolism |
1 |
|
dna-directed rna polymerases - metabolism |
1 |
|
dogs |
1 |
|
dose-response relationship, drug |
1 |
|
down syndrome - diagnosis |
1 |
|
down syndrome - diagnosis - embryology |
1 |
|
down-regulation |
1 |
|
embryo, mammalian - drug effects |
1 |
|
emerging infectious disease |
1 |
|
endonucleases - metabolism |
1 |
|
entropy |
1 |
|
eye proteins |
1 |
|
feasibility studies |
1 |
|
fetal blood - chemistry |
1 |
|
fetal blood - chemistry - metabolism |
1 |
|
fetal cell |
1 |
|
fetal diseases - diagnosis |
1 |
|
fetal dna |
1 |
|
fetal rna |
1 |
|
fetus - metabolism |
1 |
|
gene expression regulation, viral - drug effects |
1 |
|
genomic imprinting |
1 |
|
glycosylation |
1 |
|
hela cells |
1 |
|
hemagglutinin |
1 |
|
heterozygote |
1 |
|
homeodomain proteins |
1 |
|
in situ hybridization, fluorescence |
1 |
|
influenza a virus - drug effects - enzymology - genetics - physiology |
1 |
|
influenza a virus - enzymology |
1 |
|
influenza a virus - genetics - metabolism |
1 |
|
influenza a virus, h1n1 subtype - genetics - physiology |
1 |
|
influenza a virus, h3n2 subtype - genetics - physiology |
1 |
|
influenza a virus, h7n7 subtype - genetics - physiology |
1 |
|
influenza, human - genetics |
1 |
|
intercalating agents - pharmacology |
1 |
|
kidney |
1 |
|
maternal plasma |
1 |
|
maternal-fetal exchange |
1 |
|
mesoderm - drug effects - metabolism |
1 |
|
mice, inbred icr |
1 |
|
models, biological |
1 |
|
mouse embryo |
1 |
|
mutagenesis |
1 |
|
nervous system - drug effects - embryology - metabolism |
1 |
|
nervous system malformations - chemically induced - embryology |
1 |
|
neural tissue |
1 |
|
neurons |
1 |
|
neutralization assay |
1 |
|
noninvasive |
1 |
|
nucleic acid conformation |
1 |
|
oligonucleotide array sequence analysis - methods |
1 |
|
orthomyxoviridae |
1 |
|
orthomyxoviridae - genetics |
1 |
|
paired box transcription factors |
1 |
|
phosphorus radioisotopes |
1 |
|
plasma dna |
1 |
|
plasmids - metabolism |
1 |
|
plasmodium |
1 |
|
poly a - metabolism |
1 |
|
poly u - metabolism |
1 |
|
polymorphism, single nucleotide |
1 |
|
pregnancy - blood |
1 |
|
prenatal diagnosis |
1 |
|
prenatal diagnosis - methods |
1 |
|
promoter regions, genetic |
1 |
|
proteins - drug effects - metabolism |
1 |
|
pseudovirus |
1 |
|
recombination, genetic |
1 |
|
recombination, genetic - genetics |
1 |
|
repressor proteins |
1 |
|
retinoic acid |
1 |
|
rna - blood |
1 |
|
rna polymerase ii - metabolism |
1 |
|
rna replicase - metabolism |
1 |
|
rna, complementary - chemistry |
1 |
|
rna, messenger - biosynthesis |
1 |
|
rna, messenger - biosynthesis - chemistry - metabolism |
1 |
|
rna, messenger - biosynthesis - genetics |
1 |
|
rna, messenger - blood |
1 |
|
rna, messenger - chemistry - metabolism |
1 |
|
rna, messenger - genetics - metabolism |
1 |
|
rna, messenger - metabolism |
1 |
|
rna, viral - biosynthesis - genetics |
1 |
|
rna, viral - chemistry |
1 |
|
rna, viral - chemistry - metabolism |
1 |
|
rna, viral - physiology - ultrastructure |
1 |
|
s-protein |
1 |
|
sars virus - classification - genetics - isolation & purification |
1 |
|
single-strand specific dna and rna endonucleases - metabolism |
1 |
|
structure-activity relationship |
1 |
|
systems biology |
1 |
|
tail - cytology - drug effects - embryology |
1 |
|
tail bud |
1 |
|
templates, genetic |
1 |
|
transcription factors |
1 |
|
transcription, genetic |
1 |
|
transcription, genetic - drug effects |
1 |
|
transfection |
1 |
|
tretinoin - metabolism - pharmacology |
1 |
|
viral evolution |
1 |
|
viral rna |
1 |
|
virion - genetics |
1 |
|
virology |
1 |
|
vrna |
1 |
|
wnt proteins |
1 |
|
wnt-3a |
1 |
|
wnt3 protein |
1 |
|
wnt3a protein |
1 |
|
y chromosome |
1 |
|
zinc fingers |
1 |
